Effect of pravastatin on sympathetic reinnervation in postinfarcted rats

Tsung-Ming Lee, Mei S. Lin, Nen Chung Chang

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

We assessed whether pravastatin attenuates cardiac sympathetic reinnervation after myocardial infarction through the activation of ATP-sensitive K+ (KATP) channels. Epidemiological studies have shown that men treated with statins appear to have a lower incidence of sudden death than men without statins. However, the specific factor for this has remained disappointingly elusive. Twenty-four hours after ligation of the anterior descending artery, male Wistar rats were randomized to groups treated with either vehicle, nicorandil (a specific mitochondrial KATP channel agonist), pinacidil (a nonspecific KATP channel agonist), pravastatin, glibenclamide (a KATP channel blocker), or a combination of nicorandil and glibenclamide, pinacidil and glibenclamide, or pravastatin and glibenclamide for 4 wk. Myocardial norepinephrine levels revealed a significant elevation in vehicle-treated rats at the remote zone compared with sham-operated rats (2.54 ± 0.17 vs. 1.26 ± 0.36 μg/g protein, P <0.0001), consistent with excessive sympathetic reinnervation after infarction. Immunohistochemical analysis for tyrosine hydroxylase, growth-associated factor 43, and neurofilament also confirmed the change of myocardial norepinephrine. This was paralleled by a significant upregulation of tyrosine hydroxylase protein expression and mRNA in vehicle-treated rats, which was reduced after the administration of either nicorandil, pinacidil, or pravastatin. Arrhythmic scores during programmed stimulation in vehicle-treated rats were significantly higher than those treated with pravastatin. In contrast, the beneficial effects of pravastatin were reversed by the addition of glibenclamide, implicating KATP channels as the relevant target. The sympathetic reinnervation after infarction is modulated by the activation of KATP channels. Chronic use of pravastatin after infarction, resulting in attenuated sympathetic reinnervation by the activation of KATP channels, may modify the arrhythomogenic response to programmed electrical stimulation.

Original languageEnglish
Pages (from-to)H3617-H3626
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume293
Issue number6
DOIs
Publication statusPublished - Dec 2007

Fingerprint

Pravastatin
KATP Channels
Glyburide
Pinacidil
Nicorandil
Infarction
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Tyrosine 3-Monooxygenase
Norepinephrine
Intermediate Filaments
Sudden Death
Electric Stimulation
Ligation
Wistar Rats
Epidemiologic Studies
Intercellular Signaling Peptides and Proteins
Proteins
Up-Regulation
Arteries
Adenosine Triphosphate

Keywords

  • Immunohistochemistry
  • Ion channels
  • Myocardial infarction
  • Norepinephrine
  • Polymerase chain reaction

ASJC Scopus subject areas

  • Physiology

Cite this

Effect of pravastatin on sympathetic reinnervation in postinfarcted rats. / Lee, Tsung-Ming; Lin, Mei S.; Chang, Nen Chung.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 293, No. 6, 12.2007, p. H3617-H3626.

Research output: Contribution to journalArticle

@article{5941f15c1f664ba5b4fb896af7b4ca08,
title = "Effect of pravastatin on sympathetic reinnervation in postinfarcted rats",
abstract = "We assessed whether pravastatin attenuates cardiac sympathetic reinnervation after myocardial infarction through the activation of ATP-sensitive K+ (KATP) channels. Epidemiological studies have shown that men treated with statins appear to have a lower incidence of sudden death than men without statins. However, the specific factor for this has remained disappointingly elusive. Twenty-four hours after ligation of the anterior descending artery, male Wistar rats were randomized to groups treated with either vehicle, nicorandil (a specific mitochondrial KATP channel agonist), pinacidil (a nonspecific KATP channel agonist), pravastatin, glibenclamide (a KATP channel blocker), or a combination of nicorandil and glibenclamide, pinacidil and glibenclamide, or pravastatin and glibenclamide for 4 wk. Myocardial norepinephrine levels revealed a significant elevation in vehicle-treated rats at the remote zone compared with sham-operated rats (2.54 ± 0.17 vs. 1.26 ± 0.36 μg/g protein, P <0.0001), consistent with excessive sympathetic reinnervation after infarction. Immunohistochemical analysis for tyrosine hydroxylase, growth-associated factor 43, and neurofilament also confirmed the change of myocardial norepinephrine. This was paralleled by a significant upregulation of tyrosine hydroxylase protein expression and mRNA in vehicle-treated rats, which was reduced after the administration of either nicorandil, pinacidil, or pravastatin. Arrhythmic scores during programmed stimulation in vehicle-treated rats were significantly higher than those treated with pravastatin. In contrast, the beneficial effects of pravastatin were reversed by the addition of glibenclamide, implicating KATP channels as the relevant target. The sympathetic reinnervation after infarction is modulated by the activation of KATP channels. Chronic use of pravastatin after infarction, resulting in attenuated sympathetic reinnervation by the activation of KATP channels, may modify the arrhythomogenic response to programmed electrical stimulation.",
keywords = "Immunohistochemistry, Ion channels, Myocardial infarction, Norepinephrine, Polymerase chain reaction",
author = "Tsung-Ming Lee and Lin, {Mei S.} and Chang, {Nen Chung}",
year = "2007",
month = "12",
doi = "10.1152/ajpheart.00875.2007",
language = "English",
volume = "293",
pages = "H3617--H3626",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "6",

}

TY - JOUR

T1 - Effect of pravastatin on sympathetic reinnervation in postinfarcted rats

AU - Lee, Tsung-Ming

AU - Lin, Mei S.

AU - Chang, Nen Chung

PY - 2007/12

Y1 - 2007/12

N2 - We assessed whether pravastatin attenuates cardiac sympathetic reinnervation after myocardial infarction through the activation of ATP-sensitive K+ (KATP) channels. Epidemiological studies have shown that men treated with statins appear to have a lower incidence of sudden death than men without statins. However, the specific factor for this has remained disappointingly elusive. Twenty-four hours after ligation of the anterior descending artery, male Wistar rats were randomized to groups treated with either vehicle, nicorandil (a specific mitochondrial KATP channel agonist), pinacidil (a nonspecific KATP channel agonist), pravastatin, glibenclamide (a KATP channel blocker), or a combination of nicorandil and glibenclamide, pinacidil and glibenclamide, or pravastatin and glibenclamide for 4 wk. Myocardial norepinephrine levels revealed a significant elevation in vehicle-treated rats at the remote zone compared with sham-operated rats (2.54 ± 0.17 vs. 1.26 ± 0.36 μg/g protein, P <0.0001), consistent with excessive sympathetic reinnervation after infarction. Immunohistochemical analysis for tyrosine hydroxylase, growth-associated factor 43, and neurofilament also confirmed the change of myocardial norepinephrine. This was paralleled by a significant upregulation of tyrosine hydroxylase protein expression and mRNA in vehicle-treated rats, which was reduced after the administration of either nicorandil, pinacidil, or pravastatin. Arrhythmic scores during programmed stimulation in vehicle-treated rats were significantly higher than those treated with pravastatin. In contrast, the beneficial effects of pravastatin were reversed by the addition of glibenclamide, implicating KATP channels as the relevant target. The sympathetic reinnervation after infarction is modulated by the activation of KATP channels. Chronic use of pravastatin after infarction, resulting in attenuated sympathetic reinnervation by the activation of KATP channels, may modify the arrhythomogenic response to programmed electrical stimulation.

AB - We assessed whether pravastatin attenuates cardiac sympathetic reinnervation after myocardial infarction through the activation of ATP-sensitive K+ (KATP) channels. Epidemiological studies have shown that men treated with statins appear to have a lower incidence of sudden death than men without statins. However, the specific factor for this has remained disappointingly elusive. Twenty-four hours after ligation of the anterior descending artery, male Wistar rats were randomized to groups treated with either vehicle, nicorandil (a specific mitochondrial KATP channel agonist), pinacidil (a nonspecific KATP channel agonist), pravastatin, glibenclamide (a KATP channel blocker), or a combination of nicorandil and glibenclamide, pinacidil and glibenclamide, or pravastatin and glibenclamide for 4 wk. Myocardial norepinephrine levels revealed a significant elevation in vehicle-treated rats at the remote zone compared with sham-operated rats (2.54 ± 0.17 vs. 1.26 ± 0.36 μg/g protein, P <0.0001), consistent with excessive sympathetic reinnervation after infarction. Immunohistochemical analysis for tyrosine hydroxylase, growth-associated factor 43, and neurofilament also confirmed the change of myocardial norepinephrine. This was paralleled by a significant upregulation of tyrosine hydroxylase protein expression and mRNA in vehicle-treated rats, which was reduced after the administration of either nicorandil, pinacidil, or pravastatin. Arrhythmic scores during programmed stimulation in vehicle-treated rats were significantly higher than those treated with pravastatin. In contrast, the beneficial effects of pravastatin were reversed by the addition of glibenclamide, implicating KATP channels as the relevant target. The sympathetic reinnervation after infarction is modulated by the activation of KATP channels. Chronic use of pravastatin after infarction, resulting in attenuated sympathetic reinnervation by the activation of KATP channels, may modify the arrhythomogenic response to programmed electrical stimulation.

KW - Immunohistochemistry

KW - Ion channels

KW - Myocardial infarction

KW - Norepinephrine

KW - Polymerase chain reaction

UR - http://www.scopus.com/inward/record.url?scp=36849074336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36849074336&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00875.2007

DO - 10.1152/ajpheart.00875.2007

M3 - Article

C2 - 17890424

AN - SCOPUS:36849074336

VL - 293

SP - H3617-H3626

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 6

ER -